Prognostic Evaluation of Feline Mammary Carcinomas: A Review of the Literature

Veterinary Pathology

Volumn 52, Issue 1, 2015, Pages 46-60

  Zappulli, Valentina ^a   Rasotto, R ^b   Caliari, D ^a   Mainenti, M ^a   Pena L ^c   Goldschmidt, M H ^d   Kiupel, M ^e  

^a UNIVERSITY OF PADOVA   (Italy)

^b ANIMAL HEALTH TRUST   (United Kingdom)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

breast cancer; carcinoma; cats feline mammary tumors; grading; markers staging; prognosis

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL; BREAST TUMOR; CANCER GRADING; CAT; CAT DISEASE; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; HUMAN; METABOLISM; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; RETROSPECTIVE STUDY; VETERINARY;

ANIMALS; BIOMARKERS; BREAST NEOPLASMS; CAT DISEASES; CATS; FEMALE; HUMANS; MAMMARY NEOPLASMS, ANIMAL; NEOPLASM GRADING; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84920059634     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985814528221     Document Type: Article

References (105)

1. Badve S,Dabbs DJ,Schnitt SJ, et al.Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.Mod Pathol. 2011;24:157-67
2. Bethlehem M,van der Luer RJ.Feline fibro-epithelial hyperplasia in 3 castrated tomcats following treatment with progestagens.Tijdschr Diergeneeskd. 1993;118:650-652
3. Borrego JF,Cartagena JC,Engel J.Treatment of feline mammary tumors using chemotherapy, surgery and a COX-2 inhibitor drug (meloxicam): a retrospective study of 23 cases (2002–2007)*.Vet Comp Oncol. 2009;7:213-221
4. Burrai GP,Mohammed SI,Miller MA, et al.Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions.BMC Cancer. 2010;10:156
5. Castagnaro M,Casalone C,Bozzetta E, et al.Tumour grading and the one-year post-surgical prognosis in feline mammary carcinomas.J Comp Pathol. 1998;119:263-275
6. Castagnaro M,Casalone C,Ru G, et al.Argyrophilic nucleolar organiser regions (AgNORs) count as indicator of post-surgical prognosis in feline mammary carcinomas.Res Vet Sci. 1998;64:97-100
7. Castagnaro M,De Maria R,Bozzetta E, et al.Ki-67 index as indicator of the post-surgical prognosis in feline mammary carcinomas.Res Vet Sci. 1998;65:223-226
8. Cheang MC,Voduc D,Bajdik C, et al.Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.Clin Cancer Res. 2008;14:1368-1376
9. de M Souza CH,Toledo-Piza E,Amorin R, et al.Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment.Can Vet J. 2009;50:506-510
10. De Maria R,Olivero M,Iussich S, et al.Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer.Cancer Res. 2005;65:907-912
11. De Vico G,Maiolino P.Prognostic value of nuclear morphometry in feline mammary carcinomas.J Comp Pathol. 1997;117:99-105
12. Doré M.Cyclooxygenase-2 expression in animal cancers.Vet Pathol. 2011;48:254-265
13. Doré M,Lanthier I,Sirois J.Cyclooxygenase-2 expression in canine mammary tumors.Vet Pathol. 2003;40:207-212
14. Elston CW,Ellis IO.Pathological prognostic factors in breast cancer: I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.Histopathology. 1991;19:403-410
15. Elston CW,Ellis IO,Pinder SE.Prognostic factors in invasive carcinoma of the breast.Clin Oncol (R Coll Radiol). 1998;10:14-17
16. Faratian D.Systems pathology.Breast Cancer Res. 2010;12 (suppl 4): S4
17. Foulkes WD,Stefansson IM,Chappuis PO, et al.Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.J Natl Cancer Inst. 2003;95:1482-1485
18. Fox LE,MacEwen EG,Kurzman ID, et al.Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of feline mammary adenocarcinoma: a multicenter randomized double-blind study.Cancer Biother. 1995;10:125-130
19. Giménez F,Hecht S,Craig LE, et al.Early detection, aggressive therapy: optimizing the management of feline mammary masses.J Feline Med Surg. 2010;12:214-224
20. Goldschmidt M,Peña L,Rasotto R, et al.Classification and grading of canine mammary tumors.Vet Pathol. 2011;48:117-131
21. Gregório H,Pires I,Seixas F, et al.Mammary invasive micropapillary carcinoma in a male cat: Immunohistochemical description and clinical follow-up.Acta Vet Hung. 2012;60:257-261
22. Hahn KA,Adams WH.Feline mammary neoplasia: biological behavior, diagnosis, and treatment alternatives.Feline Pract. 1977;25:5-11
23. Hahn KA,Bravo L,Avenelli JS.Feline breast carcinoma as a pathologic and therapeutic model for human breast cancer.In Vivo. 1994;8:825-828
24. Hayden DW,Barnes DM,Johnson KH.Morphologic changes in the mammary gland of megestrol acetate-treated and untreated cats: a retrospective study.Vet Pathol. 1989;26:104-113
25. Hayden DW,Nielsen SW.Feline mammary tumours.J Small Anim Pract. 1971;12:687-698
26. Hayes AA,Mooney S.Feline mammary tumors.Vet Clin North Am Small Anim Pract. 1985;15:513-520
27. Hayes HM,Milne KL,Mandell CP.Epidemiological features of feline mammary carcinoma.Vet Rec. 1981;108:476-479
28. Hughes K,Dobson JM.Prognostic histopathological and molecular markers in feline mammary neoplasia.Vet J. 2012;194:19-26
29. Ito T,Kadosawa T,Mochizuki M, et al.Prognosis of malignant mammary tumor in 53 cats.J Vet Med Sci. 1996;58:723-726
30. Jacobs TM,Hoppe BR,Poehlmann CE, et al.Mammary adenocarcinomas in three male cats exposed to medroxyprogesterone acetate (1990–2006).J Feline Med Surg. 2010;12:169-174
31. Jeglum KA,deGuzman E,Young KM.Chemotherapy of advanced mammary adenocarcinoma in 14 cats.J Am Vet Med Assoc. 1985;187:157-160
32. Jurka P,Max A.Treatment of fibroadenomatosis in 14 cats with aglepristone: changes in blood parameters and follow-up.Vet Rec. 2009;165:657-660
33. Kamstock DA,Fredrickson R,Ehrhart EJ.Lipid-rich carcinoma of the mammary gland in a cat.Vet Pathol. 2005;42:360-362
34. Lana SE,Rutteman GR,Withrow SJSmall Animal Clinical Oncology. 4th ed. St Louis, MO: Saunders Elsevier; 2007:619–636.Withrow SWMacEwen EG, ed. St Louis, MO: Saunders Elsevier; 2007:619-636.
35. Leidinger E,Hooijberg E,Sick K, et al.Fibroepithelial hyperplasia in an entire male cat: cytologic and histopathological features.Tierarztl Prax Ausg K Kleintiere Heimtiere. 2011;39:198-202
36. Loukopoulos P,Sutton RH,Lynch P, et al.Ectopic mammary carcinoma in a male cat.Vet Rec. 2007;160:203-204
37. MacEwen EG,Hayes AA,Harvey HJ, et al.Prognostic factors for feline mammary tumors.J Am Vet Med Assoc. 1984;185:201-204
38. MacEwen EG,Hayes AA,Mooney S, et al.Evaluation of effect of levamisole on feline mammary cancer.J Biol Response Mod. 1984;3:541-546
39. Maniscalco L,Iussich S,de Las Mulas JM, et al.Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours.Vet J. 2012;191:65-71
40. Martin PM,Cotard M,Mialot JP, et al.Animal models for hormone-dependent human breast cancer: relationship between steroid receptor profiles in canine and feline mammary tumors and survival rate.Cancer Chemother Pharmacol. 1984;12:13-17
41. Martín de las Mulas J,Millán Y,Bautista MJ, et al.Oestrogen and progesterone receptors in feline fibroadenomatous change: an immunohistochemical study.Res Vet Sci. 2000;68:15-21
42. Martín de las Mulas J,Millán Y,Dios R.A prospective analysis of immunohistochemically determined estrogen receptor α and progesterone receptor expression and host tumor factors as predictors of disease-free period in mammary tumors of the dog.Vet Pathol. 2005;42:200-212
43. Martín de las Mulas J,van Niel M,Millán Y, et al.Immunohistochemical analysis of estrogen receptors in feline mammary gland benign and malignant lesions: comparison with biochemical assay.Domest Anim Endocrinol. 2000;18:111-125
44. Martín de las Mulas J,van Niel M,Millán Y, et al.Progesterone receptors in normal, dysplastic and tumourous feline mammary glands: comparison with oestrogen receptors status.Res Vet Sci. 2002;72:153-161
45. Matos JF,Baptista CS,Gärtner MF, et al.Prognostic studies of canine and feline mammary tumours: the need for standardized procedures.Vet J. 2012;193:24-31
46. Mauldin GN,Matus RE,Patnaik AK, et al.Efficacy and toxicity of doxorubicin and cyclophosphamide used in the treatment of selected malignant tumors in 23 cats.J Vet Intern Med. 1988;2:60-65
47. Mayr B,Blauensteiner J,Edlinger A, et al.Presence of p53 mutations in feline neoplasms.Res Vet Sci. 2000;68:63-70
48. Mayr B,Reifinger M,Loupal G.Polymorphisms in feline tumour suppressor gene p53: mutations in an osteosarcoma and a mammary carcinoma.Vet J. 1998;155:103-106
49. Mayr B,Schaffner G,Kurzbauer R, et al.Sequence of an exon of tumour suppressor p53 gene: a comparative study in domestic animals: mutation in a feline solid mammary carcinoma.Br Vet J. 1995;151:325-329
50. Miki Y,Swensen J,Shattuck-Eidens D, et al.A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.Science. 1994;266:66-71
51. Millanta F,Calandrella M,Bari G, et al.Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.Res Vet Sci. 2005;79:225-232
52. Millanta F,Calandrella M,Citi S, et al.Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential.Vet Pathol. 2005;42:30-34
53. Millanta F,Calandrella M,Vannozzi I, et al.Steroid hormone receptors in normal, dysplastic and neoplastic feline mammary tissues and their prognostic significance.Vet Rec. 2006;158:821-824
54. Millanta F,Citi S,Della Santa D.COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers.Breast Cancer Res Treat. 2006;98:115-120
55. Millanta F,Lazzeri G,Mazzei M, et al.MIB-1 labeling index in feline dysplastic and neoplastic mammary lesions and its relationship with postsurgical prognosis.Vet Pathol. 2002;39:120-126
56. Millanta F,Lazzeri G,Vannozzi I, et al.Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas.Vet Pathol. 2002;39:690-696
57. Millanta F,Silvestri G,Vaselli C, et al.The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammari carcinomas: a preliminary study of autocrine and paracrine loops.Res Vet Sci. 2006;81:350-357
58. Misdorp W.Progestagens and mammary tumours in dogs and cats.Acta Endocrinol (Copenh). 1991;125 (suppl 1): 27-31
59. Misdorp W,Else RW,Hellme’n E, et alInternational Histological Classification of Tumors of Domestic Animals. World Heath Organization, ed. Washington, DC: Armed Forces Institute of Pathology, American Registry of Pathology; 1999:11-56.
60. Misdorp W,Romijn A,Hart AA.Feline mammary tumors: a case-control study of hormonal factors.Anticancer Res. 1991;11:1793-1797
61. Misdorp W,Weijer K.Animal model of human disease: breast cancer.Am J Pathol. 1980;98:573-576
62. Morris JS,Nixon C,Bruck A, et al.Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERalpha and p53.Vet J. 2008;175:218-226
63. Morris SR,Carey LA.Molecular profiling in breast cancer.Rev Endocr Metab Disord. 2007;8:185-198
64. Murakami Y,Tateyama S,Rungsipipat A, et al.Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats.J Vet Med Sci. 2000;62:743-750
65. Nakagawa T,Uyama R,Ohashi E, et al.The expression of sialyl Lewis X in canine and feline mammary gland tumors.J Vet Med Sci. 2002;64:949-952
66. Nakano M,Wu H,Taura Y, et al.Immunohistochemical detection of Mdm2 and p53 in feline mammary gland tumors.J Vet Med Sci. 2006;68:421-425
67. Nasir L,Krasner H,Argyle DJ, et al.Immunocytochemical analysis of the tumour suppressor protein (p53) in feline neoplasia.Cancer Lett. 2000;155:1-7
68. Nielsen SW.The malignancy of mammary tumors in cats.Mod Vet Pract. 1967;33:245-252
69. Nielsen TO,Hsu FD,Jensen K, et al.Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.Clin Cancer Res. 2004;10:5367-5374
70. Ordás J,Millán Y,de los Monteros AE, et al.Immunohistochemical expression of progesterone receptors, growth hormone and insulin growth factor-I in feline fibroadenomatous change.Res Vet Sci. 2004;76:227-233
71. Ordás J,Millán Y,Dios R, et al.Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study.BMC Cancer. 2007;7:179
72. Overley B,Shofer FS,Goldschmidt MH, et al.Association between ovariohysterectomy and feline mammary carcinoma.J Vet Intern Med. 2005;19:560-563
73. Owen LNTNM Classification of Tumours in Domestic Animals. Geneva, Switzerland: World Health Organization; 1980:
74. Peña L,De Andrés PJ,Clemente M, et al.Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics.Vet Pathol. 2013;50:94-105
75. Pérez-Alenza MD,Jiménez A,Nieto AI, et al.First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases.Breast Cancer Res. 2004;6:R300-R307
76. Pires I,Silva F,Queiroga FL.Invasive micropapillary mammary carcinoma in a male cat: first report.Vet Pathol. 2008;45:723
77. Preziosi R,Sarli G,Benazzi C, et al.Detection of proliferating cell nuclear antigen (PCNA) in canine and feline mammary tumours.J Comp Pathol. 1995;113:301-313
78. Preziosi R,Sarli G,Benazzi C, et al.Multiparametric survival analysis of histological stage and proliferative activity in feline mammary carcinomas.Res Vet Sci. 2002;73:53-60
79. Rakha EA,Reis-Filho JS,Baehner F, et al.Breast cancer prognostic classification in the molecular era: the role of histological grade.Breast Cancer Res. 2010;12:207
80. Rasotto R,Caliari D,Castagnaro M, et al.An immunohistochemical study of HER-2 expression in feline mammary tumours.J Comp Path. 2011;144:170-179
81. Rasotto R,Zappulli V,Castagnaro M, et al.A retrospective study of those histopathologic parameters predictive of invasion of the lymphatic system by canine mammary carcinomas.Vet Pathol. 2012;49:330-340
82. Ressel L,Millanta F,Caleri E, et al.Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.Vet Pathol. 2009;46:860-868
83. Rutteman GR,Withrow SJ,MacEwen EGSmall Animal Clinical Oncology. 3rd ed. Philadelphia, PA: WB Saunders Co; 2001:467–473.Withrow SWMacEwen EG, ed. Philadelphia, PA: WB Saunders Co; 2001:467-473.
84. Sarli G,Benazzi C,Preziosi R, et al.Evaluating mitotic activity in canine and feline solid tumors: standardizing the parameter.Biotech Histochem. 1999;74:64-76
85. Sarli G,Preziosi R,Benazzi C, et al.Rate of apoptosis in feline mammary tumors is not predictive of postsurgical survival.J Vet Diagn Invest. 2003;15:115-122
86. Sayasith K,Sirois J,Doré M.Molecular characterization of feline COX-2 and expression in feline mammary carcinomas.Vet Pathol. 2009;46:423-429
87. Seixas F,Palmeira C,Pires MA, et al.Are complex carcinoma of the feline mammary gland and other invasive mammary carcinoma identical tumours? Comparison of clinicopathologic features, DNA ploidy and follow up.Res Vet Sci. 2008;84:428-433
88. Seixas F,Palmeira C,Pires MA, et al.Grade is an independent prognostic factor for feline mammary carcinomas: a clinicopathological and survival analysis.Vet J. 2011;187:65-71
89. Seixas F,Palmeira C,Pires MA, et al.Mammary invasive micropapillary carcinoma in cats: clinicopathologic features and nuclear DNA content.Vet Pathol. 2007;44:842-848
90. Seixas F,Pires MA,Lopes CA.Complex carcinomas of the mammary gland in cats: pathological and immunohistochemical features.Vet J. 2008;176:210-215
91. Silver IA.The anatomy of the mammary gland of the dog and cat.J Small Anim Pract. 1966;7:689-696
92. Skorupski KA,Overley B,Shofer FS, et al.Clinical characteristics of mammary carcinoma in male cats.J Vet Intern Med. 2005;19:52-55
93. Sorlie T,Perou AM,Tibshirani R, et al.Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.Proc Natl Acad Sci U S A. 2001;98:10869-10874
94. Spugnini EP,Mezzanotte F,Freri L, et al.Cyproterone acetate-induced mammary carcinoma in two male cats.J Feline Med Surg. 2010;12:515-516
95. Tanabe S,Nakadai T,Furuoka H, et al.Expression of mRNA of chemokine receptor CXCR4 in feline mammary adenocarcinoma.Vet Rec. 2002;151:729-733
96. van’t Veer LJ,Dai H,van de Vijver MJ, et al.Gene expression profiling predicts clinical outcome of breast cancer.Nature. 2002;415:530-536
97. Viste JR,Myers SL,Singh B, et al.Feline mammary adenocarcinoma: tumor size as a prognostic indicator.Can Vet J. 2002;43:33-37
98. Webster JD,Dennis MM,Dervisis N, et al.Recommended guidelines for the conduct and evaluation of prognostic studies in veterinary oncology.Vet Pathol. 2011;48:7-18
99. Weijer K,Hart AA.Prognostic factors in feline mammary carcinoma.J Natl Cancer Inst. 1983;70:709-716
100. Weijer K,Head KW,Misdorp W, et al.Feline malignant mammary tumors: I. Morphology and biology: some comparisons with human and canine mammary carcinomas.J Natl Cancer Inst. 1972;49:1697-1704
101. Wiese DA,Thaiwong T,Yuzbasiyan-Gurkan V, et al.Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.BMC Cancer. 2013;13:403
102. Winston J,Craft DM,Scase TJ, et al.Immunohistochemical detection of HER-2/neu expression in spontaneous feline mammary tumours.Vet Comp Oncol. 2005;3:8-15
103. Wooster R,Bignell G,Lancaster J, et al.Identification of the breast cancer susceptibility gene BRCA2.Nature. 1995;378:789-792
104. Yakunina MN,Treshalina EM.Systemic taxotere chemotherapy for metastatic tumor pleurisy in cats with spontaneous breast cancer.Bull Exp Biol Med. 2011;150:642-644
105. Zappulli V,Caliari D,Rasotto R, et al.Proposed classification of the feline “complex” mammary tumors as ductal and intraductal papillary mammary tumors [published online June 4, 2013].Vet Pathol. 2013;: